Indaptus Therapeutics Inc (INDP)
2.49
+0.14
(+5.96%)
USD |
NASDAQ |
May 22, 16:00
2.45
-0.04
(-1.61%)
After-Hours: 20:00
Indaptus Therapeutics Enterprise Value: 10.32M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 10.32M |
| May 20, 2024 | 9.898M |
| May 17, 2024 | 9.983M |
| May 16, 2024 | 10.75M |
| May 15, 2024 | 9.642M |
| May 14, 2024 | 8.446M |
| May 13, 2024 | 8.361M |
| May 10, 2024 | 8.617M |
| May 09, 2024 | 8.062M |
| May 08, 2024 | 7.934M |
| May 07, 2024 | 7.763M |
| May 06, 2024 | 7.592M |
| May 03, 2024 | 7.507M |
| May 02, 2024 | 7.379M |
| May 01, 2024 | 7.560M |
| April 30, 2024 | 8.788M |
| April 29, 2024 | 8.376M |
| April 26, 2024 | 8.275M |
| April 25, 2024 | 8.873M |
| April 24, 2024 | 10.32M |
| April 23, 2024 | 11.52M |
| April 22, 2024 | 11.09M |
| April 19, 2024 | 10.41M |
| April 18, 2024 | 11.78M |
| April 17, 2024 | 12.97M |
| Date | Value |
|---|---|
| April 16, 2024 | 14.08M |
| April 15, 2024 | 12.61M |
| April 12, 2024 | 13.91M |
| April 11, 2024 | 13.74M |
| April 10, 2024 | 11.78M |
| April 09, 2024 | 11.26M |
| April 08, 2024 | 10.62M |
| April 05, 2024 | 11.09M |
| April 04, 2024 | 9.471M |
| April 03, 2024 | 9.471M |
| April 02, 2024 | 10.24M |
| April 01, 2024 | 9.898M |
| March 28, 2024 | 5.765M |
| March 27, 2024 | 7.900M |
| March 26, 2024 | 10.55M |
| March 25, 2024 | 7.814M |
| March 22, 2024 | 6.448M |
| March 21, 2024 | 6.021M |
| March 20, 2024 | 6.448M |
| March 19, 2024 | 4.143M |
| March 18, 2024 | 3.118M |
| March 15, 2024 | 2.606M |
| March 14, 2024 | 2.947M |
| March 13, 2024 | 3.716M |
| March 12, 2024 | 4.314M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.16M
Minimum
Jun 17 2022
52.06M
Maximum
Sep 29 2021
-0.726M
Average
-2.176M
Median
Enterprise Value Benchmarks
| Quoin Pharmaceuticals Ltd | -11.70M |
| CEL-SCI Corp | 65.64M |
| AIM ImmunoTech Inc | 13.35M |
| IGC Pharma Inc | 31.45M |
| NovaBay Pharmaceuticals Inc | 5.64M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.807M |
| Total Expenses (Quarterly) | 3.943M |
| EPS Diluted (Quarterly) | -0.45 |
| Earnings Yield | -71.49% |